素酶PADI4与脂质结合:识别癌症治疗新目标相互作用
Salomé Araujo-Abad1, Borja García-Peñarrubia2, A Marcela Giudici3
1Cancer Research Group, Faculty of Engineering and Applied Sciences, Universidad de Las Américas, 170124 Quito, Ecuador.
Journal of molecular biology
|June 18, 2025
概括
这项研究揭示了PADI4酶与酸丁胺 (PS),酸丁胆 (PC) 和酸 (PA) 等脂质结合. 这种发生在PADI4活动地点的相互作用对了解癌症发展和潜在的新疗法有影响.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 癌症细胞依赖于改变的脂质代谢来生存,脂质如酸胺 (PS),酸胆 (PC) 和酸 (PA) 起着至关重要的作用.
- 丁氨酸脱酶4 (PADI4) 是一种与癌症发展相关的酶,参与素化.
研究的目的:
- 为了研究PADI4.4的脂质结合特性.
- 在体外和癌细胞中探索PADI4与关键膜脂质的相互作用.
- 为了确定PADI4-脂质相互作用在癌症生物学中的相关性.
主要方法:
- 在体外结合测定使用生物物理技术与PC,PA和PS脂质.
- 在基分子建模中,预测结合点.
- 在使用免疫光 (IF) 和近距离结合试验 (PLA) 在具有PS的癌细胞系中进行的细胞质验证中.
- 使用GSK484.4进行PADI4的药理抑制.
主要成果:
- 在实验室中,PADI4显示了对PA,PC和PS脂质的结合亲和力.
- 在分析表明,PADI4在其活性部位与这些脂质结合.
- 在纤维化实验中证实了PADI4与癌细胞中的PS结合.
- PADI4 抑制剂 GSK484 消除了癌细胞中的 PADI4-PS 结合,证实了活性位点的相互作用.
结论:
- PADI4直接与特定的膜脂质结合,包括PS,PC和PA.
- 这种PADI4的脂质结合能力发生在它的活性部位,在癌细胞中是相关的.
- 这些发现为研究PADI4在癌症中的作用和开发脂向癌症疗法开辟了新的途径.
相关概念视频
Phosphoinositides and PIPs
8.7K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.7K
Cancer Cell Migration through Invadopodia
2.4K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.4K
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Targets for Drug Action: Overview
7.5K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.5K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
IP3/DAG Signaling Pathway
12.5K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.5K


